China Medical University Hospital

TAICHUNG, Oct. 10, 2024 /PRNewswire/ -- China Medical University Hospital (CMUH, Taiwan) continues to make significant strides in cell therapy, demonstrating its leadership on the global stage. Ms. Lin, a patient with malignant glioma, underwent tumor removal surgery followed by radiation therapy and dendritic cell immunotherapy. After four years of follow-up, her condition remains stable, and she maintains an excellent quality of life. Continue Reading Dr. Chen Chun-Chung (right), Chief of CMUH’s Neurosurgery Department, representing the Taiwan Neurosurgical Society, signed an MOU with Prof. Dato Dr. Abdul Rahman Izaini Ghani, President of the Neurosurgical Association of Malaysia, in Kuching, Malaysia. This agreement makes a significant milestone in neurosurgical collaboration between Taiwan and Malaysia, offering Malaysian neurosurgeons streamlined access to Taiwan’s advanced medical technologies. "Malignant gliomas are notoriously challenging to treat," said Dr. Chen Chun-Chung, Director of Neurosurgery at CMUH. "Thanks to Ms. Lin's positive attitude and the advanced cell therapy, we've achieved promising outcomes." On September 14, three CMUH physicians were invited to speak at the Sarawak Neurosurgery Update & Neurosurgical Association of Malaysia Annual Scientific Meeting 2024 (NAM-SNU ASM 2024). Dr. Chen Chun-Chung highlighted the success of CMUH's cell therapy, while representatives from the Taiwanese and Malaysian Neurosurgical Societies signed a Memorandum of Understanding (MOU), strengthening medical exchange and collaboration between the two countries. Taiwan's First Participation in NAM-SNU ASM: A Milestone in Taiwan-Malaysia Medical Exchange Following the successful "Taiwan-Malaysia Neurosurgery Advanced Medical Summit 2024" in July, Taiwan made its debut participation at NAM-SNU ASM 2024. Dr. Chen Chun-Chung, alongside Dr. Brian Chiu Cheng-Di, Director of Minimally Invasive Spine Neurosurgery, and Dr. Chuang Hao-Yu, Director of the Cell Therapy Center at Tainan City An Nan Hospital, were invited to present at the conference. This marked the first time Taiwanese physicians participated in the event. The MOU signed between the Taiwan Neurosurgical Society (TNS) and the Neurosurgical Association of Malaysia (NAM) is seen as a key development in Taiwan-Malaysia neurosurgical collaboration. Cutting-edge Neurosurgical Techniques Spark Interest from Malaysian Physicians At CMUH physicians presented on cutting-edge neurosurgical techniques, including treatments for brain cancer, stroke, and endoscopic spine surgery. Their presentations attracted significant attention and sparked enthusiastic discussions among conference attendees. Dr. Chen shared the success story of Ms. Lin, diagnosed with malignant glioma in 2000 after experiencing seizures. Despite the challenges of treating this aggressive brain cancer, Ms. Lin underwent surgery, radiation therapy, and dendritic cell immunotherapy, receiving ten vaccine injections. Her progress has been closely monitored for over four years, showing significant improvement. Dr. Chen highlighted those traditional treatments for malignant glioma, primarily radiation and limited targeted therapies, offer an average survival rate of just 15 months. However, at CMUH, the average survival has risen to 23 months, with Ms. Lin surpassing the four-year milestone. CMUH's cell therapy program is now advancing into CAR-T cell therapy, promising even better outcomes for cancer patients. "We are excited to share our clinical experience in cell therapy with our Malaysian colleagues and continue to promote the exchange of medical expertise," said Dr. Chen. Dr. Brian Chiu Cheng-Di highlighted Taiwan's extensive clinical experience in endoscopic spine surgery, which allows for minimally invasive procedures with faster recovery times. The technique is especially beneficial for spinal disc removal, spinal stenosis, and tumor surgeries, though more careful assessment is required for cases involving structural abnormalities or malignancies. Following Dr. Chiu's presentation, three Malaysian experts signed up for advanced training in Taiwan. Dr. Chuang Hao-Yu presented on two key areas of Taiwan's neurosurgery advancements. The first focused on intracerebral hemorrhagic stroke, which has a higher incidence in Asia than in Western countries, and how Taiwan's minimally invasive surgery techniques significantly reduce mortality and neurological disabilities. The second highlighted Taiwan's progress in interventional vascular treatments, developed through collaborative efforts of six major medical societies. Strengthening Taiwan-Malaysia Medical Cooperation Chou Aichi, CEO of CMUH's International Center, emphasized that neurosurgery has been a focal point for Taiwan-Malaysia medical exchanges for the past three years under the Ministry of Health and Welfare's "New Southbound Medical and Health Cooperation and Industry Development" initiative. The partnership includes seminars, hospital visits, health lectures, and physician training in Taiwan. At this year's conference, Taiwanese companies Brain Navi Biotechnology and EPED Inc. showcased Taiwan's cutting-edge medical technologies. The MOU signed between TNS and NAM strengthens opportunities for Malaysian neurosurgeons to benefit from Taiwan's advanced innovations. This collaboration marks a significant milestone in Taiwan's New Southbound Policy, further promoting medical partnerships across Southeast Asia. Contact: Carolyn Chen [email protected] SOURCE China Medical University Hospital WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Security concerns and vendor restrictions are some of the major barriers to unlocking health data's full potential in raising patient outcomes. In the HIMSS24 APAC plenary session, "Power of Data in Modern Healthcare," Cho Chi-Heum, professor and president of Keimyung University Dongsan Medical Center in South Korea, and Dr Shih-Sheng Chang, director of the Artificial Intelligence Center at China Medical University Hospital (CMUH) in Taiwan, discussed challenges in data integration and interoperability. To allow their doctors to securely share patient data, Keimyung Hospital has in place an ISM (information security management) system, which is at the core of its data privacy and security strategy. "We strictly follow personal information protection guidelines also," added Prof Cho. Common vendor arrangements also hinder hospitals from generating valuable insights from comprehensive, integrated data. Some vendors may allow multi-source data integrations, but this usually comes with hefty costs due to proprietary data usage rights, noted Dr Chang. "Sometimes, they will provide very fancy software which includes [all] data, but we cannot pay for each." Dr Chang and his team have learned to approach this problem by taking this initial step: "If we want to set up a new machine or a new modality, we will ask the vendor, 'Can you share the data with us? Otherwise, we will consider another vendor.'" Driving efficiencies The two speakers also discussed how their clinicians have wasted time doing tedious administrative tasks. "Most doctors in Korea just always look at their computers. They are so busy [with their computers] that they cannot [meet] their patients… I don't wish to see this kind of hospital," Prof Cho shared. Nurses, meanwhile, spend 60% of their time doing repetitive tasks, particularly checking patients' vital signs. "This is very repeated and [mechanical]." According to Prof Cho, Keimyung Hospital is looking to implement wearable devices as part of remote patient monitoring to help nurses save time. Meanwhile, as part of its data quality management – and by extension, AI development, CMUH is also considering large language models (LLM) to build a system for structured data. Through LLMs, Dr Chang said, clinicians would not have to create structured clinical reports, which may take up to 30 minutes each. Prof Cho however cautions against over-relying on computer software, particularly those running on AI. "We are human beings. We are not AI; we are just using AI." At Keimyung Hospital, he envisions an "emotional hospital" that prioritises meeting patients eye-to-eye. "AI cannot replace the human. But it can [help] save time to let us have [that] eye contact with our patients," Dr Chang said, echoing Prof Cho's statement.

HIMSS today announced an update to its Adoption Model for Analytics Maturity at the HIMSS24 Asia-Pacific conference in Seoul. The earlier version of AMAM will now be referred to as AMAM Classic and the modernised version will be referred to as AMAM24. WHY IT MATTERS The new AMAM maturity framework centres on five key imperatives for healthcare organisations: Governance; Analytics life cycle; Data and infrastructure; Personalised analytics; and Analytics impact and outcomes. HIMSS redesigned the AMAM to enable the successful adoption of advanced analytics, and AI in particular, for health organisations to achieve priority outcomes. It begins with the foundational requirements of data, digital infrastructure, and governance. Like the other HIMSS maturity models, AMAM24 is structured around a ladder of eight maturity stages - from zero to seven - to help healthcare organisations optimise their healthcare analytics capabilities, offering an evidence-based framework for improving data governance, predictive analytics, and AI usage. THE LARGER TREND Globally, 26 organisations achieved Stage 6 and 13 have achieved Stage 7 for the AMAM. In APAC, two organisations ( China Medical University Hospital , and Seoul National University Bundang Hospital) have reached AMAM Stage 6. South Korea's Samsung Medical Centre is the only organisation in APAC to have achieved Stage 7 . ON THE RECORD "AMAM24 does not prescribe what policy framework should be used in an organisation; however, it does require evidence of analytics strategy and governance policies which support and enable safety and quality of care," said Widi Salim, Senior Digital Health Advisor, HIMSS. "AMAM24 expands its earlier focus on data and IT to also now include prescriptive analytics, and data driven decision making."